Ignite Creation Date:
2025-12-25 @ 2:14 AM
Ignite Modification Date:
2026-05-13 @ 9:10 AM
Study NCT ID:
NCT00158860
Status:
COMPLETED
Last Update Posted:
2019-02-15
First Post:
2005-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Comparing Daily Treatment With Valaciclovir To Placebo For Suppression Of Herpes Simplex Virus HSV-2 Genital Herpes In Newly Diagnosed Patients. VALTREX® Tablet is a Trademark of the GlaxoSmithKline Group of Companies.
Sponsor:
GlaxoSmithKline
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
HS2100275
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None